𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Urinary matrix metalloproteinase activity is not significantly altered in patients with renal cell carcinoma

✍ Scribed by Glenn M. Cannon Jr; Robert H. Getzenberg

Book ID
116945569
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
144 KB
Volume
67
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Matrix-metalloproteinases and their inhi
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma
✍ Michael Lein; Klaus Jung; Christian Laube; Tobias HΓΌbner; Bjoern Winkelmann; Car πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 70 KB πŸ‘ 2 views

Matrix-metalloproteinases (MMPs) are associated with invasive and metastatic behavior of several human malignant tumors. We have determined MMP-2 and MMP-9 and tissue inhibitors of MMPs (TIMP-1 and TIMP-2) in blood plasma and in renal tissue samples of patients with renal cell carcinoma (RCC) from c

A single nucleotide polymorphism in the
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma
✍ Hiroshi Hirata; Katsusuke Naito; Satoru Yoshihiro; Hideyasu Matsuyama; Yutaka Su πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 63 KB πŸ‘ 2 views

## Abstract Matrix metalloproteinase (MMP)‐1 is associated with tumor cell invasion and metastasis, and its promoter polymorphism has been shown to influence the transcriptional level. Our study explored the association between this polymorphism and renal cell carcinoma in a Japanese population. DN